Novel Approaches for Targeting Thymidylate Synthase To Overcome the Resistance and Toxicity of Anticancer Drugs

被引：46
|
作者：
Garg, Divita [1 ,2 ]
Henrich, Stefan [1 ]
Salo-Ahen, Outi M. H. [1 ,3 ]
Myllykallio, Hannu [4 ]
Costi, Maria P. [5 ]
Wade, Rebecca C. [1 ]
机构：
[1] Heidelberg Inst Theoret Studies gGmbH, Mol & Cellular Modeling Grp, Heidelberg, Germany
[2] Helmholtz Zentrum Munchen, Inst Biol Struct, Neuherberg, Germany
[3] Abo Akad Univ, Dept Biosci, Turku, Finland
[4] Ecole Polytech, CNRS, INSERM, Lab Opt & Biosci,UMR7645,U696, F-91128 Palaiseau, France
[5] Univ Modena & Reggio Emilia, Dipartimento Sci Farmaceut, Modena, Italy
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2010年 / 53卷 / 18期
关键词：
HISTONE DEACETYLASE INHIBITOR; ENHANCES 5-FLUOROURACIL CYTOTOXICITY; MESSENGER-RNA TRANSLATION; GENE-EXPRESSION; CELL-GROWTH; DIHYDROFOLATE-REDUCTASE; ANTITUMOR-ACTIVITY; DOWN-REGULATION; HUMAN LIVER; IN-VITRO;
D O I：
10.1021/jm901869w
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
[No abstract available]
引用
收藏
页码：6539 / 6549
页数：11
相关论文
共 50 条
  • [1] Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance
    Taddia, Laura
    D'Arca, Domenico
    Ferrari, Stefania
    Marraccini, Chiara
    Seveni, Leda
    Ponterini, Glauco
    Assaraf, Yahuda G.
    Marverti, Gaetano
    Costi, Maria Paola
    DRUG RESISTANCE UPDATES, 2015, 23 : 20 - 54
  • [2] Antifolate Inhibitors of Thymidylate Synthase as Anticancer Drugs
    Jarmula, A.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2010, 10 (13) : 1211 - 1222
  • [3] Isolation and characterization of a novel intermediate of thymidylate synthase: Possibility of a new class of chemotherapeutic drugs targeting thymidylate synthase
    Ghosh, Ananda K.
    Kholodar, Svetlana A.
    Kohen, Amnon
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [4] Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase
    Banerjee, D
    Mayer-Kuckuk, P
    Capiaux, G
    Budak-Alpdogan, T
    Gorlick, R
    Bertino, JR
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2002, 1587 (2-3): : 164 - 173
  • [5] Folate-based thymidylate synthase inhibitors as anticancer drugs
    Jackman, AL
    Calvert, AH
    ANNALS OF ONCOLOGY, 1995, 6 (09) : 871 - 881
  • [6] Targeting CAFs to overcome anticancer therapeutic resistance
    Er Saw, Phei
    Chen, Jianing
    Song, Erwei
    TRENDS IN CANCER, 2022, 8 (07) : 527 - 555
  • [7] The means to an end of tumor cell resistance to chemotherapeutic drugs targeting thymidylate synthase: Shoot the messenger
    Berg, RW
    Ferguson, PJ
    DeMoor, JM
    Vincent, MD
    Koropatnick, J
    CURRENT DRUG TARGETS, 2002, 3 (04) : 297 - 309
  • [8] Nanomedicine targeting ferroptosis to overcome anticancer therapeutic resistance
    Jing Cai
    Xiaoding Xu
    Phei Er Saw
    Science China Life Sciences, 2024, 67 : 19 - 40
  • [9] Nanomedicine targeting ferroptosis to overcome anticancer therapeutic resistance
    Cai, Jing
    Xu, Xiaoding
    Saw, Phei Er
    SCIENCE CHINA-LIFE SCIENCES, 2024, 67 (01) : 19 - 40
  • [10] Nanomedicine targeting ferroptosis to overcome anticancer therapeutic resistance
    Jing Cai
    Xiaoding Xu
    Phei Er Saw
    Science China(Life Sciences), 2024, 67 (01) : 19 - 40
12345